{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "16956512",
  "DateCompleted": {
    "Year": "2007",
    "Month": "02",
    "Day": "20"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "09",
    "Day": "17"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "spa"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1695-4033",
      "JournalIssue": {
        "Volume": "65",
        "Issue": "3",
        "PubDate": {
          "Year": "2006",
          "Month": "Sep"
        }
      },
      "Title": "Anales de pediatria (Barcelona, Spain : 2003)",
      "ISOAbbreviation": "An Pediatr (Barc)"
    },
    "ArticleTitle": "[Psoriasis and anxiety: marked improvement after anxiolytic therapy].",
    "Pagination": {
      "StartPage": "271",
      "EndPage": "272",
      "MedlinePgn": "271-2"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Figueroa Quintana",
        "ForeName": "A",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "D\u00edez Su\u00e1rez",
        "ForeName": "A",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Espa\u00f1a Alonso",
        "ForeName": "A",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Soutullo Esper\u00f3n",
        "ForeName": "C",
        "Initials": "C"
      }
    ],
    "PublicationTypeList": [
      "Case Reports",
      "Letter"
    ],
    "VernacularTitle": "Psoriasis en relaci\u00f3n con ansiedad, mejor\u00eda marcada tras tratamiento ansiol\u00edtico."
  },
  "MedlineJournalInfo": {
    "Country": "Spain",
    "MedlineTA": "An Pediatr (Barc)",
    "NlmUniqueID": "101162596",
    "ISSNLinking": "1695-4033"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Anxiety Agents"
    },
    {
      "RegistryNumber": "63FN7G03XY",
      "NameOfSubstance": "Clorazepate Dipotassium"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Anxiety Agents"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy"
      ],
      "DescriptorName": "Anxiety"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child, Preschool"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Clorazepate Dipotassium"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "drug therapy",
        "etiology"
      ],
      "DescriptorName": "Psoriasis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Remission Induction"
    }
  ]
}